By CreakyStaff
Exciting news for Australians with chronic plaque psoriasis. Two breakthrough treatments have been added to the PBS, bringing fresh possibilities for those with this challenging condition.
By CreakyStaff
Updated advice from the Australian Rheumatology Association about the timing and use of COVID-19 vaccines for rheumatology patients.
By CreakyStaff
Australian children with juvenile idiopathic arthritis may soon have a new treatment option. Here’s how you can help us get this medication subsidised through the Pharmaceutical Benefits Scheme.
By CreakyStaff
Were you transitioned to another medicine during the tocilizumab (Actemra®) shortage? Now that it is available again, you can speak with your rheumatologist about your ongoing treatment options.
By CreakyStaff
Until recently, people with chronic plaque psoriasis needed to visit their dermatologist whenever they needed a new prescription for apremilast. Now, their GP can issue subsequent prescriptions, potentially saving patients time and money.
Medicinal cannabis has been legal in Australia since 2016. However, access is still limited and more data is needed to determine its benefits for many conditions.
By CreakyStaff
Do you use Orencia to treat your inflammatory arthritis? Have you been affected by the current supply shortage? Here are the options available to you.
By CreakyStaff
Limited supply of tocilizumab (Actemra®) is now on the way for some Australians with inflammatory conditions such as rheumatoid arthritis.
Guselkumab (Tremfya®) is a new treatment option for Australians with psoriatic arthritis – an autoimmune form of arthritis closely connected with psoriasis.
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
By CreakyStaff
Rheumatoid arthritis pain isn’t easy to manage when providers can’t see and touch your joints in person, but you can discuss and treat RA pain during telehealth visits. Here’s how.
By CreakyStaff
CreakyJoints Australia launched the inaugural edition of A Patient’s Guide to Living with Axial Spondyloarthritis in Australia as a free download from their website today to coincide with World Arthritis Day.
Without opioids, my life is sedentary. By taking my opioids away, my pain management doctor is increasing my risk of obesity, heart disease and disability. Not to mention severe, daily pain.
By CreakyStaff
It can be a big adjustment to give yourself injections. These tips can make the process less scary.
By CreakyStaff
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.
What should you do if you can’t access Plaquenil? Are you at risk of COVID-19 exposure if you have a biologic infusion in a hospital? We’ve got the answers you’ve been seeking.
By CreakyStaff
Do you regularly attend face-to-face health appointments such as medication reviews, physiotherapy and blood tests? Should you still go during the lockdown?
By CreakyStaff
The question on everyone’s lips is when will we have a cure for COVID-19?
By CreakyStaff
The new OA guidelines are designed more like a menu from which patients and providers can choose one or more approved items.
By CreakyStaff
It’s not surprising that you can feel arthritis in your feet: The disease predominantly affects your joints, and your foot contains more than 30 of them.
Tofacitinib (Xeljanx®) is now available on the Pharmaceutical Benefits Scheme (PBS) for those diagnosed with psoriatic arthritis.
On 1 March, 2019, ixekizumab (Taltz®), was added to the Pharmaceutical Benefits Scheme (PBS) to give adults with severe psoriatic arthritis more treatment options. Previously, Australian adults had been able to access the medication, but at a cost of around...
This steroid is commonly prescribed to help with RA flares. Here’s what you need to know before you start it.
A new study compared infection risks among different biologics for RA — and Orencia came out ahead.
By 
By 
By 
By 
